TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
15 hedge funds and large institutions have $1.1M invested in Titan Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
3
Closed
2
Calls
$720K
Puts
$211K
Net Calls
+$509K
Net Calls Change
+$69K
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$139K |
2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$63K |
3 |
ARTA
A.R.T. Advisors
New York
|
+$55.2K |
4 |
VF
Virtu Financial
New York
|
+$50K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
+$32.7K |
Top Sellers
1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$162K |
2 |
UBS Group
Zurich,
Switzerland
|
-$6.67K |
3 |
Morgan Stanley
New York
|
-$5K |
4 |
WPA
Winning Points Advisors
Boca Raton,
Florida
|
-$3.16K |